Montelukast plus inhaled budesonide versus double dose inhaled budesonide in nonasthmatic eosinophilic bronchitis
Chuang Cai(Zhongshan People's Hospital), Nanshan Zhong(State Key Laboratory of Respiratory Disease), Zhong Shuqing(First Affiliated Hospital of Guangzhou Medical University), Yan Tang(Shanghai East Hospital)
Cited by 0
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247